Michelle Burwell, PA
Physician Assistant · Mount Vernon, ILNPI 1841239316
Payments from drug & device makers
Across 167 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$791
- AstraZeneca$374
- AbbVie$266
- Lilly USA, LLC$256
- Amgen$250
- Abbott$236
- plus $797 from 21 others
What the payments were for
- Food & beverage$2,968100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $791 |
| AstraZeneca(2 entities) | 21 | $374 |
| AbbVie | 13 | $266 |
| Lilly USA, LLC | 12 | $256 |
| Amgen | 12 | $250 |
| Abbott | 12 | $236 |
| Mylan Specialty L.p. | 6 | $120 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $63 |
| Nestle Healthcare Nutrition Inc. | 4 | $63 |
| Dexcom, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 1 | $54 |
| Bayer | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Tris Pharma Inc | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Pfizer | 1 | $19 |
| Harmony Biosciences LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
How this compares
$2,968 in reported general payments places this provider in the 85th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 27 | $34,434 |
| EliquisApixaban | 37 | $29,913 |
| FarxigaDapagliflozin Propanediol | 33 | $24,123 |
| MounjaroTirzepatide | 21 | $22,792 |
| OzempicSemaglutide | 23 | $22,075 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 12 | $17,541 |
| XareltoRivaroxaban | 15 | $13,093 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $11,405 |
| LinzessLinaclotide | 12 | $6,508 |
| VascepaIcosapent Ethyl | 16 | $5,341 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 14 | $4,213 |
| Atorvastatin Calcium | 247 | $2,641 |
| Metoprolol Succinate | 146 | $2,614 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,243 |
| Omeprazole | 112 | $2,228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $256 | $57,22648 claims |
| PfizerEliquis, Abrysvo | $19 | $34,12751 claims |
| AstraZenecaFarxiga | $374 | $24,12333 claims |
| Novo NordiskOzempic | $791 | $22,07523 claims |
| Johnson & JohnsonXarelto | $15 | $13,09315 claims |
| AbbVieLinzess, Synthroid | $266 | $7,35530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Mount Vernon
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.